Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment. (Q35185010)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Danilo Marimpietri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Emilio Cosimo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Mirco Ponzoni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Fabio Pastorino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Chiara Brignole

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Theresa M Allen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

231-235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12880987%20AND%20SRC:MED&resulttype=core&format=json

Molecular biology of neuroblastoma

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

Therapeutic Applications of Oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

Targeted delivery of antisense oligonucleotides in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021

A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900107-1

7 January 2021